WO2004000809A1 - Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays - Google Patents

Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays Download PDF

Info

Publication number
WO2004000809A1
WO2004000809A1 PCT/EP2003/006370 EP0306370W WO2004000809A1 WO 2004000809 A1 WO2004000809 A1 WO 2004000809A1 EP 0306370 W EP0306370 W EP 0306370W WO 2004000809 A1 WO2004000809 A1 WO 2004000809A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
group
hydrogen
methyl
direct bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/006370
Other languages
English (en)
French (fr)
Inventor
Andreas MÜHLEBACH
Peter Nesvadba
Andreas Kramer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba Spezialitaetenchemie Holding AG
Ciba SC Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU2003279373A priority Critical patent/AU2003279373A1/en
Priority to KR1020047021209A priority patent/KR101015028B1/ko
Priority to EP03740262A priority patent/EP1515950B1/en
Priority to CA002486958A priority patent/CA2486958A1/en
Priority to AT03740262T priority patent/ATE450509T1/de
Priority to US10/519,030 priority patent/US7595359B2/en
Application filed by Ciba Spezialitaetenchemie Holding AG, Ciba SC Holding AG filed Critical Ciba Spezialitaetenchemie Holding AG
Priority to JP2004514745A priority patent/JP4640936B2/ja
Priority to MXPA04012885A priority patent/MXPA04012885A/es
Priority to DE60330340T priority patent/DE60330340D1/de
Publication of WO2004000809A1 publication Critical patent/WO2004000809A1/en
Anticipated expiration legal-status Critical
Priority to US12/535,747 priority patent/US7902368B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82BNANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94Oxygen atom, e.g. piperidine N-oxide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Definitions

  • the instant invention relates to cationic alkoxyamines, which are useful as polymerization initiators/regulators in a controlled free radical polymerization process to produce intercalated and/or exfoliated nanoparticles from natural or synthetic clays.
  • the invention also relates to improved nanocomposite compositions produced by this process and to the use of these nanocomposite compositions as, for example, coatings, sealants, caulks, adhesives and as plastic additives.
  • One way of improving polymer properties is by adding a natural or synthetic clay material to polymers to form composite materials.
  • incorporating clays into polymers may not provide a desirable improvement in the physical properties, particularly mechanical and optical properties of the polymer may be adversely affected.
  • Nanonocomposite compositions containing finely dispersed natural or synthetic clay with at least partially intercalated and/or exfoliated layers and mixtures of ethylenically unsaturated monomers and/or polymers therefrom have therefore attracted much interest in the last years. These materials combine the desired effects of dispersed clay by avoiding the negative influence on, for example, the mechanical or optical properties.
  • compositions, methods for making them and their use in polymers and coatings are for example described in WO 02/24759.
  • Polymerization processes are described using mont- morillonite clay, acrylate monomers and for example ammonium persulfate as radical initiator. This conventional polymerization process leads to polymers with broad molecular weight distributions and a high polydispersity index (PD).
  • PD polydispersity index
  • the present invention provides alkoxyamines, which can be anchored to natural or synthetic clays by a cationic anchor group and which have a high reactivity towards acrylates, methacrylates, styrene and other monomers resulting in a controlled molecular weight with narrow molecular weight distribution. With these compounds polymerization leads to high monomer to polymer conversions in short times and at relatively low temperatures.
  • controlled radical polymerization allows to adjust the molecular weight of all growing chains almost uniformly to a predetermined length (low polydispersity), resulting in an almost ideal dispersion of the intercalated and/or exfoliated clay particles.
  • the nanocomposite compositions of the instant invention can be optically almost transparent, indicating the fine distribution, on the nanometer scale, of the clay.
  • One aspect of the invention is a compound of formula (I) or (II)
  • Gi and G 2 independently represent a tertiary carbon atom to which unsubstituted d-d ⁇ alkyl or phenyl or with CN, COC r C 18 alkyl, CO-phenyl, COOC r C ⁇ 8 alkyl, Od-C 18 alkyl, N0 2> NHC C ⁇ 8 alkyl or N(d-C 18 ) 2 alkyl substituted alkyl or phenyl groups are bonded; or one of G, and G 2 is a secondary carbon atom to which a group -P(O)(OR 22 ) 2 and the other is as defined above; or
  • Gj and G 2 together with the nitrogen atom to which they are bonded to form a 5 to 8 membered heterocyclic ring or a polycyclic or spirocyclic 5 to 20 membered heterocyclic ring system, which is substituted with 4 d-C 4 alkyl groups or 2 C 5 -C 12 spirocycloalkyl groups in ortho position to the nitrogen atom and which may be further substituted with one or more C
  • C 18 alkyl, C C 18 alkoxy or O groups; and which may be interrupted by a further oxygen or nitrogen atom; with the proviso that at least one of the 4 d-C 4 alkyl groups in ortho position to the nitrogen atom is higher alkyl than methyl;
  • Lj, L 2 and L 4 is a linking group selected from the group consisting of a direct bond, Rj-Y or R 2 -C(O)-Y- where Y is attached to G ⁇ and or G 2 ; d-C 25 alkylene,
  • Y is O, or NR 9 L 3 is a group containing at least one carbon atom and is such that the radical •L 3 -(Q + X " ) derived from the group is able to initiate polymerization of ethylenically unsaturated monomers;
  • Q 2 is a direct bond, O, NR 5 or NR 5 R 6 ;
  • Q + is a cationic group selected from the group consisting of
  • R T is d-C ⁇ 8 alkylene
  • R 2 is a direct bond or C C 18 alkylene
  • R 3 is hydrogen or C r C ⁇ 8 alkyl
  • R 4 is hydrogen or d-C 18 alkyl
  • R 5 , R 6 and R 7 are each independently of the others hydrogen, d-C 18 alkyl,
  • R 5 , R 6 and R 7 together with the nitrogen or phosphor atom to which they are bonded form a 3-12 membered monocyclic or polycyclic ring, which may contain further heteroatoms;
  • R 8 is hydrogen or C ⁇ -C 25 alkyl, C 3 -C 25 alkyl interrupted by oxygen, sulfur or by
  • R 9 is hydrogen, d-C ⁇ 8 alkyl, C 3 -C 18 alkenyl, C 3 -C 18 alkinyl, phenyl, C 7 -C 9 phenylalkyl, which all may be unsubstituted or substituted by one or more hydroxy, halogen or C dalkoxy groups;
  • R 22 is d-C 18 alkyl
  • X " is the anion of a CrC 18 carboxylic acid which may contain more than one carboxylic acid group, fluoride, chloride, bromide, iodide, nitrite, nitrate, hydroxide, acetate, hydrogen sulfate, sulfate, d-C 18 alkoxy sulfate, aromatic or aliphatic sulfonate, carbonate, hydrogen carbonate, perchlorate, chlorate, tetrafluoroborate, borate, phosphate, hydrogenphosphate, dihydrogenphosphate or mixtures thereof; and p, q, and r are independently of each other a number from 0 to 10 and at least one is different from 0.
  • Alkyl having up to 18 carbon atoms is a branched or unbranched radical, for example methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, 2-ethylbutyl, n-pentyl, isopentyl, 1-methylpentyl, 1 ,3-dimethylbutyl, n-hexyl, 1-methylhexyl, n-heptyl, isoheptyl, 1 ,1 ,3,3-tetra- methylbutyl, 1 -methylheptyl, 3-methylheptyl, n-octyl, 2-ethylhexyl, 1 ,1 ,3-trimethylhexyl, 1 ,1 ,3,3-tetramethylpentyl, nonyl, decyl, undecyl, 1-methylundecyl, dode
  • R 3 is, for example, CH 3 -0-CH 2 CH 2 -,
  • CH 3 -S-CH 2 CH 2 - CH 3 -N(CH 3 )-CH 2 CH 2 - , CH 3 -O-CH 2 CH 2 -O-CH 2 CH 2 - , CH 3 -(0-CH 2 CH 2 -) 2 O-CH 2 CH 2 - , CH 3 -(O-CH 2 CH 2 -) 3 O-CH 2 CH 2 - or CH 3 -(0-CH 2 CH 2 -) 4 O-CH 2 CH 2 -.
  • Phenylalkyl is, for example, benzyl, ⁇ -methylbenzyl, ⁇ , ⁇ -dimethylbenzyl or 2-phenyl- ethyl. Preference is given to benzyl and ⁇ , ⁇ -dimethylbenzyl.
  • d-C 25 Alkylene is a branched or unbranched radical, for example methylene, ethylene, pro- pylene, trimethylene, tetramethylene, pentamethylene, hexamethylene, heptamethyiene, octamethylene, decamethylene, dodecamethylene or octadecamethylene. 0 0
  • phenylene or C 5 -C 8 cycloalkylene is, for example,
  • Alkenyl having 2 to 24 carbon atoms is a branched or unbranched radical such as, for example, vinyl, propenyl, 2-butenyl, 3-butenyl, isobutenyl, n-2,4-pentadienyl, 3-methyl-2- butenyl, n-2-octenyl, n-2-dodecenyl, iso-dodecenyl, oleyl, n-2-octadecenyl or n-4-octadece- nyl.
  • Preference is given to alkenyl having 3 to 18, especially 3 to 12, for example 3 to 6, especially 3 to 4 carbon atoms.
  • Alkinyl having from 3 to 18 carbon atoms is a branched or unbranched radical, for example propinyl, 2-butinyl, 3-butinyl, isobutinyl, n-2,4-pentadiinyl, 3-methyl-2-butinyl, n-2-octinyl, n-2- dodecinyl, isododecinyl.
  • Halogen is, for example, chlorine, bromine or iodine. Preference is given to chlorine and bromine.
  • Alkoxy having up to 25 carbon atoms is a branched or unbranched radical, for example methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, isobutoxy, pentyloxy, isopentyloxy, hexyl- oxy, heptyloxy, octyloxy, decyloxy, tetradecyloxy, hexadecyloxy or octadecyloxy.
  • Alkanoyloxy having up to 25 carbon atoms is a branched or unbranched radical, for example acetoxy, propionyloxy, butanoyloxy, pentanoyloxy, hexanoyloxy, heptanoyloxy, octanoyloxy, nonanoyloxy, decanoyloxy, undecanoyloxy, dodecanoyloxy, tridecanoyloxy, tetradecanoyl- oxy, pentadecanoyloxy, hexadecanoyloxy, heptadecanoyloxy, octadecanoyloxy, icosanoyl- oxy or docosanoyloxy.
  • Preference is given to alkanoyloxy having from 2 to 18, especially from 2 to 12, e.g. from 2 to 6, carbon atoms.
  • Hydroxyl-substituted C 2 -C 18 alkyl is a branched or unbranched radical which contains preferably 1 to 3, in particular 1 or 2, hydroxyl groups, such as, for example, hydroxyethyl, 3-hydr- oxypropyl, 2-hydroxypropyl, 4-hydroxybutyl, 3-hydroxybutyl, 2-hydroxybutyl, 5-hydroxypentyl, 4-hydroxypentyl, 3-hydroxypentyl, 2-hydroxypentyl, 6-hydroxyhexyl, 5-hydroxyhexyl, 4- hydroxyhexyl, 3-hydroxyhexyl, 2-hydroxyhexyl, 7-hydroxyheptyl, 6-hydroxyheptyl, 5-hydroxy- heptyl, 4-hydroxyheptyl, 3-hydroxyheptyl, 2-hydroxyheptyl, 8-hydroxyoctyl, 7-hydroxyoctyl, 6- hydroxyoctyl, 5-hydroxyoctyl, 4-hydroxyoctyl, 3-hydroxyoctyl, 2-hydroxy
  • C 5 -C 12 cycloalkyl is for example cyclopentyl, cyclohexyl, cycloheptyl, methylcyclopentyl or cyclooctyl.
  • X ' is a monovalent radical of a saturated, unsaturated or aromatic carboxylic acid, it is, for example, an acetyl, caproyl, stearoyl, acryloyl, methacryloyl, benzoyl or ⁇ -(3,5-di-tert-butyl-4- hydroxyphenyl)propionyl radical.
  • X ' is a divalent radical of a dicarboxylic acid, it is, for example, a malonyl, succinyl, glutaryl, adipoyl, suberoyl, sebacoyl, maleoyl, itaconyl, phthaloyl, dibutylmalonyl, dibenzylmalonyl, butyl(3,5-di-tert-butyl-4-hydroxybenzyl)malonyl or bicycloheptenedicarbonyl radical.
  • X ' is a trivalent radical of a tricarboxylic acid, it is, for example, a trimellitoyl, citryl or nitrilotriacetyl radical.
  • Heteroaryl is for example pyryl, thiophenyl, furyl, pyridyl or pyrimidyl.
  • R 5 , R 6 and R 7 form a monocyclic or polycyclic heterocyclic ring
  • the resulting cation is for example a pyridinium, quinolinium, isoquinolinium, imidazolium or thiazolium cation.
  • K, and K 2 are hydrogen, C C ⁇ 8 alkyl, C 5 -d 2 cycloalkyl, phenyl or C 7 -C 9 phenylalkyl and K 3 is a group -COI i or __ ⁇ _ z _ ⁇ where
  • K 4 is -Y-[(CH 2 -CH 2 )-(CH 2 )s-N + R 5 R 6 X ] t -CH 2 -CH 2 -(CH 2 ) s -N + R 5 R 6 7 X ' or -Y-CH 2 -CHOH-CH 2 -N + R 5 R 6 X ' - ⁇ C(CH 2 -CH 2 )-(CH 2 ) s -N + X-R 5 R 6 ] t -CH 2 -CH 2 -(CH 2 ) s -N + R 5 R 6 R 7 X ⁇ u , where s is a number 0-8, t is a number 0-4 and u is 0 or 1 and Y is -O- or -NR 9 ; or
  • K is a group or
  • Z is -C(O)- or a direct bond, if Z is -C(O)-, K 5 has the same meaning as K4, if Z is a direct bond, K 5 is Y-CH 2 -CHOH-CH 2 -N + R 5 R 6 ⁇ -- ⁇ [(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 X ' ],-CH 2 -
  • the compounds are of formulae la, lb, lc, Id or le
  • Q T is a direct bond or a -CH 2 - group; if Q 1 is a direct bond, T 8 is hydrogen, if Q. ! is -CH 2 -, T 8 is methyl or ethyl;
  • T ⁇ , T 2l T 3 and T 4 are independently methyl or ethyl with the proviso that at least one is ethyl;
  • T 7 and T 10 are independently hydrogen or methyl
  • T 5 and T 6 are hydrogen or
  • T 5 is hydrogen and T 6 is -O-T 9 or -NR 9 -T 9 where T 9 is hydrogen, R 9 or -C(0)-R 9 , where R 9 is hydrogen, d-C 18 alkyl, C 3 -C 18 alkenyl, C 3 -C 18 alkinyl, phenyl, C 7 -C 9 phenylalkyl, which may be unsubstituted or substituted by one or more hydroxy, halogen or d-C 4 alkoxy groups; 11 , T 12 , T 13 , T ⁇ 4 , T 15 and T 16 independently are C C ⁇ 8 alkyl, C 3 -C 18 alkenyl, C 3 -C 18 alkinyl, C 5 -
  • Tn is hydrogen and T 12 is a group -P(O)(OC 2 H 5 ) 2 and the others are as defined above; or Tn and T 14 are a group -CH 2 -O-T 9 and the others are as defined above; or
  • T 16 is a group -C(O)-Y-R 5 and the others are as defined above; or
  • Tn, T 12 and T 13 are a group -CH 2 OH;
  • K T and K 2 are hydrogen, C 5 -C 12 cycloalkyl, phenyl or C 7 -C 9 phenylalkyl and
  • K 3 is a group -CO or w ⁇ ere
  • K 4 is Y-[(CH 2 -CH 2 )-(CH 2 ) S -N + R 5 R 6 X ' ],-CH 2 -CH 2 -(CH 2 ) S -N + R 5 R 6 R 7 X ' or
  • K 4 is a group or
  • Z is -C(O)- or a direct bond, if Z is -C(O)- K 5 has the meaning of K 4 , if Z is a direct bond, K 5 is 0-CH 2 -CHOH-CH 2 -N + R 5 R 6 X " - ⁇ [(CH 2 -CH 2 )-(CH 2 ) S -N + R 5 R 6 X ],-CH 2 -
  • Y is -0- or -NR 9 ;
  • the compounds are of formula lla, lib, lie, lid or lie
  • Ai and A 2 are independently hydrogen or together with the carbon atom to which they are bonded form a carbonylgroup, -C(O)-;
  • D is a direct bond or d-C ⁇ alkylene, d-C 12 alkylene which is interrupted by one or more O,
  • E is a group -NR 9 -(CH 2 ) X -NR 9 - where x is a number from 2 to 12 or a group
  • v is a number from 0 to 10 and w is O or 1 ;
  • Q is a direct bond or a -CH 2 - group; if Qj is a direct bond, T 8 is hydrogen, if Q, is -CH 2 -, T 8 is hydrogen, methyl or ethyl;
  • Y is -0- or -NR 9 ; ⁇ , T 2l T 3 and T 4 are independently methyl or ethyl with the proviso that at least one is ethyl;
  • T 7 is hydrogen or methyl
  • Kj and K 2 are hydrogen, C 5 -C 12 cycloalkyl, phenyl or C 7 -C 9 phenylalkyl and K 3 is a group -COI ⁇ or _ ⁇ ⁇ ⁇ _ z _ ⁇ where
  • K 4 is Y-[(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 X " ],-CH 2 -CH 2 -(CH 2 ) S -N + R S R 6 R 7 X " or -Y-CH 2 -CH0H-CH 2 -N + R 5 R 6 X-- ⁇ [(CH 2 -CH 2 )-(CH 2 ) S -N + R 5 R 6 X ⁇ ],-CH 2 -CH 2 -(CH2) S -N + R 5 R6R7 X ' ⁇ u , where s and t is a number 0-4 and u is 0 or 1 ; or
  • K 4 is a group _ Y or
  • Z is -C(O)- or a direct bond, if Z is -C(O)- K 5 has the meaning of t , if Z is a direct bond, K 5 is O-CH 2 -CHOH-CH 2 -N + R 5 R 6 ⁇ -- ⁇ [(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 X CH 2 - CH 2 -(CH 2 ) S -N + R 5 R 6 R 7 X " ⁇ u, Q + X ' , -CH 2 Q + X- or -CHCH 3 Q + X " ;
  • T 2 , T 3 and T 4 are independently methyl or ethyl with the proviso that at least one is ethyl;
  • T 7 is hydrogen or methyl
  • Y is O or NR 9 ;
  • Q is a direct bond or a -CH 2 - group; if Qj is a direct bond, T 8 is hydrogen, if Qi is -CH 2 -, T 8 is methyl or ethyl; v is a number from 0 to 10 and w is 0 or 1 ;
  • K 7 is a group -CH 2 -CHOH-CH 2 -N + R 5 R 6 ⁇ -- ⁇ [(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 X ' ],-CH 2 -CH 2 -(CH 2 ) S -
  • K 6 is selected from the group consisting of
  • C 6 cycloalkyl) 2 CCN, (C ⁇ -C 12 alkyl) 2 CCN, -CH 2 CH CH 2 , (C 1 -C 12 )alkyl-CR 3 o-C(0)-(C 1 -C 12 )alkyl, (C 1 -C 12 )alkyl-CR 3 o-C(O)-(C 6 -C 1 o)aryl, (CrC ⁇ 2 )alkyl-CR 30 -C(O)-(C ⁇ -C 12 )alkoxy, (C C 12 )alkyl- CR 30 -C(O)-phenoxy, (C 1 -C 12 )alkyl-CR 30 -C(O)-N-di(C 1 -C 12 )alkyl, (d-d 2 )alkyl-CR 3 o-CO- NH(d-C 12 )alkyl, (d-C 12 )alkyl-CR 3 o-CO-NH 2 ,
  • R 30 is hydrogen or C C 12 alkyl; the alkyl groups are unsubstituted or substituted with one or more -OH, -COOH or -C(O)R 30 groups; and the aryl groups are phenyl or naphthyl which are unsubstituted or substituted with d-
  • T ⁇ , T 2 , T 3 and T 4 are independently methyl or ethyl with the proviso that at least one is ethyl;
  • T 7 is hydrogen or methyl
  • Ej is where x is a number from 2 to 12;
  • K 6 is is selected from the group consisting of -CH 2 -aryl, alkyl(C C 18 )— _ (Cr
  • C 6 cycloalkyl) 2 CCN, (d-C 12 alkyl) 2 CCN, -CH 2 CH CH 2 , (d-C 12 )alkyl-CR 3 o-C(0)-(d-C 12 )alkyl, (C 1 -C 12 )alkyl-CR 30 -C(0)-(C 6 -Cio)aryl, (C 1 -C 12 )alkyl-CR 20 -C(O)-(C 1 -C 12 )alkoxy, (d-C 12 )alkyl- CR 30 -C(O)-phenoxy, (C 1 -C 12 )alkyl-CR 30 -C(O)-N-di(C 1 -C ⁇ 2 )alkyl, (C 1 -C 12 )alkyl-CR 30 -CO- NH(d-C 12 )alkyl, (d-C ⁇ 2 )alkyl-CR 30 -CO-NH 2 , -CH 2
  • R 30 is hydrogen or d-C 12 alkyl; the alkyl groups are unsubstituted or substituted with one or more -OH, -COOH or -C(O)R 30 groups; and the aryl groups are phenyl or naphthyl which are unsubstituted or substituted with d-
  • T 7 is hydrogen or methyl
  • Q is a direct bond or a -CH 2 - group; if Q, is a direct bond, T 8 is hydrogen, if Qi is -CH 2 -, T 8 is methyl or ethyl;
  • Kj and K 2 are hydrogen, C 5 -C 12 cycloalkyl, phenyl or C 7 -C 9 phenylalkyl and
  • K 3 is a group -CO i or // V_ 7 ⁇
  • K 4 is Y-[(CH 2 -CH 2 )-(CH 2 ) S -N + R 5 R 6 ⁇ -] t -CH 2 -CH 2 -(CH 2 ) s -N + R 5 R 6 7 X " or -Y-CH 2 -CHOH-CH 2 -N + R 5 R 6 X " - ⁇ [(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 X ' ],-CH 2 -CH 2 -(CH 2 ) S -N + R 5 R6R7 X " ⁇ u, where s and t is a number 0-4 and u is 0 or 1 ; or
  • ⁇ 5 is a group _ Y _ ⁇ _ Q + ⁇ - , _ ⁇ _ ⁇ . R6 ⁇ - or — N x or
  • Z is -C(O)- or a direct bond, if Z is -C(O)- K 5 has the meaning of j, if Z is a direct bond, K 5 is 0-CH 2 -CHOH-CH 2 -N + R 5 R 6 ⁇ -- ⁇ [(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 X ] t -CH 2 -
  • K 7 is a group -CH 2 -CHOH-CH 2 -N + R 5 R 6 ⁇ -- ⁇ [(CH 2 -CH 2 )-(CH 2 ) s -N + R 5 R 6 ⁇ -] t -CH 2 -CH 2 -(CH 2 ) s - where s and t is a number 0-4 and u is 0 or 1 ; or a group -D r Q + X ' where D, is d-C ⁇ 2 alkylene, d-C 12 alkylene which is interrupted by one or more O, S, or NR 9 atoms, C 5 -C 12 cycloalkylene or phenylene;
  • T ⁇ , T 2 , T 3 and T 4 are independently methyl or ethyl with the proviso that at least one is ethyl;
  • T 7 is hydrogen or methyl
  • E 1 is where x is a number from 2 to 12;
  • K T and K 2 are hydrogen, C 5 -C 12 cycloalkyl, phenyl or C 7 -C 9 phenylalkyl and
  • K 3 is a group -COH or — ⁇ ⁇ — z-K w ⁇ er ⁇
  • K 4 is Y-[(CH 2 -CH 2 )-(CH 2 ) S -N + R 5 R 6 X " ],-CH 2 -CH 2 -(CH 2 ) S -N + R 5 R 6 R X " or -Y-CH 2 -CHOH-CH 2 -N + R 5 R 6 X " - ⁇ [(CH2-CH 2 )-(CH 2 ) s -N + R 5 R 6 X " ],-CH2-CH2-(CH2) S -N + R 5 R6R 7 X " ⁇ u , where s and t is a number 0-4 and u is 0 or 1 ; or
  • K 4 is a group or Z is -C(O)- or a direct bond, if Z is -C(O)- K 5 has the meaning of K t , if Z is a direct bond, K 5 is 0-CH 2 -CHOH-CH 2 -N + R 5 R 6 X ' - ⁇ [(CH 2 -CH 2 )-(CH 2 ) S -N + R 5 R 6 X " ],-CH 2 - CH 2 -(CH 2 ) S -N + R 5 R 6 R 7 X " ⁇ u , Q + X " , -CH 2 Q + X " or -CHCH 3 Q + ⁇ - and X ' and the other substituents are as defined above.
  • compounds of formula Ia1 , Ib1 , Id , Id1 or Ie1 are compounds of formula Ia1 , Ib1 , Id , Id1 or Ie1
  • Qj is a direct bond or CH 2 ;
  • Tj, T 3 are ethyl and T 2 , T 4 are methyl;
  • T 7 is methyl or H; if Qj is a direct bond, T 8 is H; if Q, is CH 2 , T 8 is methyl or ethyl;
  • T 10 is H if T 7 is methyl or T 10 is methyl if T 7 is H;
  • Tn, T 12 , T 13 , T 14 , T 15 and T 16 are independently methyl or ethyl; or
  • Tn is H, T 12 is isopropyl,T ⁇ 3 is phenyl and T 1 ,T 15 ,T 16 are methyl; or
  • T is H
  • T 13 is t-butyl and T 14 , T ⁇ 5 , T 16 are methyl; or
  • T and T 14 are -CH 2 0-T 9 and T 12 , T 15 are methyl or phenyl and T 13 , T ⁇ 6 are methyl or ethyl; or
  • Tn, Ti 2 , T 13 , T 14 , T 1S are methyl and T 6 is a group -CO-0-R 9 or -CON(R 9 ) 2 , or
  • Tn, T 12 and T 13 are -CH 2 OH, T 14 is H, T 15 is isopropyl and T ⁇ 6 phenyl;
  • T 9 is hydrogen, R 9 or -C(O)-R 9 , where R 9 is hydrogen, d-C 18 alkyl, C 3 -C ⁇ 8 alkenyl, C 3 -
  • Kj is H, K 2 is methyl or ethyl and
  • K 3 is a group -CO-K4 or ⁇ _ z . ⁇ ;
  • K 4 is -Y-CH 2 -CH 2 -(CH 2 ) S -N + X-R 5 R 6 R 7 or; -Y-CH 2 -CH0H-CH 2 -N-CH 2 -CH 2 -(CH 2 ) S -N + X-R 5 R6R7 where Y is O or NR 9 and s is a number from 0 to 2; if K 3 is (/ — z . ⁇ , Z is -CO- or a direct bond;
  • K 5 has the same meaning as r i; if Z is a direct bond, K 5 is a group -0-CH 2 -CHOH-CH 2 -N-CH 2 -CH 2 -(CH 2 ) s -N + X R s R 6 R 7
  • Qj is a direct bond or CH 2 ;
  • T ⁇ , T 3 are ethyl and T 2 , T 4 and T 7 are methyl; if Qj is a direct bond, T 8 is H; if Q ! is CH 2 , T 8 is methyl or ethyl;
  • D is a direct bond, C ⁇ -C 12 alkylene or phenylene;
  • E is -NR 5 -(CH 2 ) ⁇ -NR 5 - where xis 2 to12 or a group
  • K T is H
  • K 2 is methyl or ethyl
  • K 3 is a group -CO-K4 or — ⁇ ⁇ — z-K ' •
  • K 4 is -Y-CH 2 -CH 2 -(CH 2 ) S -N + X " R 5 R 6 R 7 or;
  • Z is -CO- K 5 has the same meaning as ⁇ if Z is a direct bondK 5 is a group -0-CH 2 -CHOH-CH 2 -N-CH 2 -CH2-(CH 2 ) s -N + X R 5 R6R7 and
  • the precursors of the above compounds can be prepared according to known methods.
  • the preparation of open chain alkoxyamines is for example described in WO 99/03894 or in WO 00/07981.
  • Alkoxyamines based on tetraalkyl piperidine are for example described in GB 2 335 1290 or in GB 2 361 235. Further heterocyclic alkoxyamines are described in GB 2 342 649.
  • a very suitable, but not the only possible, method for the introduction of the cationic moiety into the molecule of the alkoxyamine consists of first preparing the suitable precursor alkoxyamine wich is then quarternised. Examples of such alkoxyamines are given in the examples in Table 1.
  • the non cationic precursors can be prepared by a variety of methods described in the cited patents using the suitable building blocks bearing the appropriate nucleophilic groups capable of quartemisation. Few examples of such groups are primary, secondary or tertiary amine group, pyridyl, quinolyl, isoquinolyl, imidazolyl, thiazolyl groups, trialkyl or triaryl or alkylarylphosphine groups or a thioether group.
  • electrophilic reagents for example alkyl halides, alkyl sulfonates, alkyl carbonates, trialkyloxonium salts, epoxides or others.
  • a special case is the formation of the cationic moiety by protonation of the cited nucleophilic groups by their protonation with acids.
  • a given specific anion of the cationic alkoxyamine can be exchanged against a different one using for example ion exchangers or well known ion metathesis.
  • a further aspect of the invention is a process for preparing a monomer/polymer clay nanocomposite dispersion comprising the steps of
  • Clay minerals are typically comprised of hydrated aluminum silicates that are fine-grained and have a platy habit.
  • the crystalline structure of a typical clay mineral is a multi-layered structure comprised of combinations of layers of SiO 4 tetrahedra that are joined to layers of AIO(OH) 2 octahedra.
  • a so called "gallery" is formed which describes the defined interlayer spaces of the layered clay minerals.
  • the gallery may contain water and/or other constituents such as potassium, sodium or calcium cations.
  • Clay minerals vary based upon the combination their constituent layers and cations.
  • Isomorphic substitution of the cations of clay mineral typically occurs and may impart a net negative charge on the clay structure. Natural occurring elements within the gallery of the clay, such as water molecules or sodium or potassium cations, are attracted to the surface of the clay layers due to this net charge.
  • Nanocomposites are compositions in which at least one of its constituents has one or more dimensions, such as length, width or thickness in the nanometer size range.
  • nanocomposite denotes the state of matter wherein polymer molecules exist among at least partially exfoliated clay layers.
  • intercalated nanocomposite describes a nanocomposite that contains a regular insertion between the clay layers.
  • exfoliated nanocomposite describes a nanocomposite wherein the 1 nm thick layers of clay are dispersed in the matrix (oligomer/polymer) forming a composite structure on the nano/micro scale.
  • the clay minerals are items of commerce and are for example supplied by S ⁇ d-Chemie Inc., Germany.
  • the ethylenically unsaturated monomer or oligomer is selected from the group consisting of ethylene, propylene, n-butylene, i-butylene, styrene, substituted styrene, conjugated dienes, acrolein, vinyl acetate, vinylpyrrolidone, vinylimidazole, maleic anhydride, (alkyl)acrylic acidanhydrides, (alkyl)acrylic acid salts, (alkyl)acrylic esters, (meth)acrylonitriles, (alkyl)acrylamides, vinyl halides or vinylidene halides.
  • R a as C 2 -C ⁇ 0 oalkoxy interrupted by at least one O atom are of formula
  • R c is CrC 25 alkyl, phenyl or phenyl substituted by C r
  • R d is hydrogen or methyl and v is a number from 1 to 50.
  • These monomers are for example derived from non ionic surfactants by acrylation of the corresponding alkoxylated alcohols or phenols.
  • the repeating units may be derived from ethylene oxide, propylene oxide or mixtures of both.
  • R a have the meaning as defined above and R ⁇ is methyl or benzyl.
  • An ' is preferably Cl ' , Br " or 0 3 S-CH 3 .
  • R a is hydrogen or methyl
  • R b is NH 2 , gycidyl, unsubstituted or with hydroxy substituted C C 4 alkoxy, unsubstituted C -C alkylamino, di(C 1 -C 4 alkyl)amino, hydroxy- substituted d-C 4 alkylamino or hydroxy-substituted di(C ⁇ -C 4 alkyl)amino
  • Z is oxygen.
  • ethylenically unsaturated monomers are styrene, methylacrylate, ethylacrylate, butylacrylate, isobutylacrylate, tert. butylacrylate, hydroxyethylacrylate, hydroxypropyl- acrylate, dimethylaminoethylacrylate, glycidylacrylates, methyl(meth)acrylate, ethyl(meth)- acrylate, butyl(meth)acrylate, hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, di- methylaminoethyl(meth)acrylate, glycidyl(meth)acrylates, acrylonitrile, acrylamide, methacryl- amide or dimethylaminopropyl-methacrylamide.
  • the ethylenically unsaturated monomer is selected from the group consisting of d-C 18 alkyl methacrylate, d-C 18 alkyl acrylate, 2-ethylhexyl (meth)acrylate, isobornyl (meth)acrylate, lauryl (meth)acrylate, allyl (meth)acrylate, stearyl (meth)acrylate, acrylic acid, itaconic acid, methacrylic acid, butadiene, vinyl acetate, vinyl versa tate, styrene, hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, vinyl aromatic monomers, divinylbenzene, divinylpyridine, divinyltoluene, diallyl phthalate, ethylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, divinylxylene, divinylethylbenzene, divinyl
  • an acid containing unsaturated monomer which is selected from the group consisting of methacrylic anhydride, maleic anhydride, itaconic anhydride, acrylic acid, methacrylic acid, itaconic acid, maleic acid, fumaric acid, acryloxypropionic acid, (meth)acryloxypropionic acid, styrene sulfonic acid, ethylmethacrylate-2-sulphonic acid, 2-acrylamido-2-methylpropane, sulphonic acid; phosphoethylmethacrylate; the corresponding salts of the acid containing monomer, and combinations thereof.
  • step A the process is carried out wherein the water phase of step A) is at least partially removed before performing step B).
  • step B) an organic solvent is additionally added.
  • Preferred is a process wherein the polymerization is carried out by applying heat, at a temperature of from 60° C to 160° C.
  • step A the process is carried out wherein a further cationic compound selected from the group of cationic surfactants is added in step A).
  • Typical surfactants are amino acids or alkylammonium ions.
  • the amino acid surfactants transfer a proton from the COOH group to the NH group forming a NH 3 + group which can exchange with a cation of the clay mineral.
  • the alkylammonium ion is CH 3 -(CH 2 ) n -NH 3 + where n is from 1 to 18. It is believed that the alkylammonium cations readily exchange with the naturally occurring cations present inbetween the clay platelets resulting in an intercalated state.
  • the clay may be a natural or synthetic clay material.
  • the clay material When the clay material is a synthetic one, it may be produced by gas-phase or sol-gel processes, for example Si0 2 , [e.g. Aerosil ® from Degussa; Ludox ® from DuPont; Snowtex ® from Nissan Chemical; Levasil ® from Bayer; or Sylysia ® from Fuji Silysia Chemical]; colloidal silica [e.g.Klebosol®], or organosols [e.g. Highlink ® OG from Clariant].
  • gas-phase or sol-gel processes for example Si0 2 , [e.g. Aerosil ® from Degussa; Ludox ® from DuPont; Snowtex ® from Nissan Chemical; Levasil ® from Bayer; or Sylysia ® from Fuji Silysia Chemical]; colloidal silica [e.g.Klebosol®], or organosols [e.g. Highlink ® OG from Clariant].
  • Typical clays are natural or synthetic phyllosilicates, which may be organophilically modified montmorillonites [e.g. Nanomer ® from Nanocor or Nanofil ® from Suedchemie], bentonites [e.g. Cloisite ® from Southern Clay Products], beidellites, hectorites, saponites, nontronites, sauconites, vermiculites, ledikites, magadiites, kenyaites or stevensites.
  • montmorillonites e.g. Nanomer ® from Nanocor or Nanofil ® from Suedchemie
  • bentonites e.g. Cloisite ® from Southern Clay Products
  • the natural or synthetic clay is selected from the group consisting of smectite, phyllosilicate, montmorillonite, saponite, beidellite, montronite, hectorite, stevensite, vermiculite, kaolinite, hallosite, synthetic phyllosilicates, and combinations thereof.
  • montmorillonite Most preferred is montmorillonite.
  • a monomer/polymer clay nanocomposite dispersion obtainable by a process as described above, a composition comprising an aqueous dispersion of a natural or synthetic clay which is partially intercalated and/or exfoliated and a compound as described above and a composition, which contains additionally an ethylenically unsaturated monomer and/or a organic solvent.
  • Yet another aspect of the invention is the use of a compound of formula I or II for the polymerization of ethylenically unsaturated monomers and the use of a monomer/polymer clay nanocomposite dispersion obtainable according to the process as defined above as additive in paints, coatings, inks, adhesives, reactive diluents or in thermoplastic materials.
  • Example A1 ⁇ 4-[1-(4-tert-butyl-2,2-diethyl-6,6-dimethyl-3-oxo-piperazine-1-yloxy)- ethyl]-benzyl ⁇ -triethyl-ammonium chloride (compound 101 , Table 1 ) a) 1-tert-butyl-4-f1-(4-chloromethyl-phenyl)-ethoxyl-3,3-diethyl-5,5-dimethyl-piperazine-2-one To a solution of 13.4 g (0.052 mol) 1-tert-butyl-3,3-diethyl-5,5-dimethyl-piperazine-2-one-4-N- oxyl (prepared according to Ger.
  • Example A2 4- ⁇ 4-[1-(4-tert-butyl-2,2-diethyl-6,6-dimethyl-3-oxo-piperazine-1-yloxy)- ethyl]-benzoyl ⁇ -1 ,1-dimethyl-piperazine-1-ium iodide (compound 102, Table 1) a) 1 -tert-butyl-3.3-diethyl-5,5-dimethyl-4-(1 -f4-(4-methyl-piperazine-1 -carbonvD-phenv ⁇ -eth- oxyl-piperazine-2-one
  • Example A3 ⁇ 3-[2-(2,6-diethyl-2,3,6-trimethyl-piperidine-1-yloxy)-propionylamino]- propyl ⁇ -ethyl-dimethyl-ammonium bromide (compound 103, Table 1) a) 2-chloro-N-(3-dimethylamino-propyD-propionamide
  • the suspension is filtered and the filter cake is washed with 100 ml ethylacetate.
  • the filtrate is washed with 3 x 100 ml water, then with 2x60 ml of a 1 % aqueous EDTA-disodiumsalt-solution and dried over MgSO 4 .
  • the residue is purified by chromatography on silica gel (hexane-ethylacetate 2:1). 7.7 g of the title compound are obtained as thick yellow oil
  • Example A4 ⁇ 3-[2-(2,6-diethyl-4-hydroxy-2,3,6-trimethyl-piperidine-1-yloxy)- propionylamino]-propyl ⁇ -ethyl-dimethyl-ammonium bromide (compound 104, Table 1 ) a) 2-(2,6-diethyl-4-hvdroxy-2,3,6-trimethyl-piperidine-1-yloxy)-.N.-(3-dimethylamino-propy ⁇ - propionamide
  • the mixture is stirred 4 h at room temperature followed by the addition of 500 ml water and 150 ml dichlormethane.
  • the organic phase is separated and the water phase is extracted with 2x100 ml dichlormethane.
  • the organic phases are washed with 5x100 ml water, then with 3x60 ml 1% aqueous EDTA-Disodiumsalt-solution, dried over MgS0 4 evaporated. 33.55 g of the title compound are obtained as thick yellow oil.
  • Example A5 [3-(2- ⁇ .N.-.tert.-butyl-.N.-[1 -(diethoxy-phosphoryl)-2,2-dimethyl-propyl]- aminooxy ⁇ -propionylamino)-propyl]-ethyl-dimethyl-ammonium bromide (compound 105, Table 1) a) (1-f.tert.-butyl-f1-(3-dimethylamino-propylcarbamoyl)-ethoxyl-aminol-2.2-dimethyl-propyl)- phosphonic acid diethyl ester
  • Example A6 ⁇ 3-[2,6-Diethyl-2,3 > 6-trimethyl-1-(1-phenyl-ethoxy)-piperidine-4-ylidene- aminooxy]-propyl ⁇ -ethyl-dimethyl-ammonium-bromide (Compound 106, Table 1) a) 2,6-Diethyl-2,3,6-trimethyl-1 -(1 -phenyl-ethoxy)-piperidine-4-one -0-(3-dimethylamino- propyD-oxime
  • Ethylbromide (7.5 ml) is added to a solution of 2,6-diethyl-2,3,6-trimethyl-1 -(1-phenyl- ethoxy)-piperidine-4-one -0-(3-dimethylamino-propyl)-oxime (10.2 g, 0.0244 mol) in acetonitrile (12 ml). The solution is stirred 24 h at room temperature and is then evaporated.
  • Example A7 ⁇ 3-[2-(2,6-Diethyl-4-hydroxy-2,3,6-trimethyl-piperidine-1-yloxy)-propionyl- amino]-propyl ⁇ -ethyl-dimethyl-ammonium-bromide-terephthalate (Compound 107, Table 1) a) Terephthalic acid bis-(2,6-diethyl-2.3.6-trimethyl-piperidine-N-oxyl-4-yl) ester Terephthaloylchloride (12.2 g, 0.06 mol) is added dropwise to a solution of 2,6-diethyl-2,3,6- trimethyl-piperidine-4-hydroxy-N-oxyl (25.72g, 0.12 mol, prepared as described in DE 19909767 A1 ) in dichloromethane (80 ml) and pyridine (30 ml).
  • Ethylbromide (7.5 ml) is added to a solution of terephthalic acid bis- ⁇ 1 -[1-(3-dimethylami-no- propylcarbamoyl)-ethoxy]-2,6-diethyl-2,3,6-trimethyl-piperidine-4-yl ⁇ ester (1 1. Og, 0.0125 mol) in acetonitrile (20 ml). The mixture is stirred at room temperature for 17 h and is then evaporated to afford 14.1g of the title compound as a colorless amorphous solid. MS (ESI), cation C 52 H 94 N 6 0 8 (930.7): found 931.8.
  • Example A8 Ethyl- ⁇ 3-[2-(4-hydroxy-2,2,6,6-tetramethyl-piperidine-1-yloxy)-propio- nylamino]-propyl ⁇ -dimethyl-ammonium-bromide (Compound 108, Table 1) a) N-(3-Dimethylamino-propyl)-2-(4-hvdroxy-2.2.6.6-tetramethyl-piperidine-1-yloxy)-pro- pionamide
  • Example A9 ⁇ 3-[2-(2,6-Diethyl-4-hydroxy-2,3,6-trimethyl-piperidine-1-yloxy)-2-methyl- propionylamino]-propyl ⁇ -ethyl-dimethyl-ammonium-bromide (Compound 109, Table 1)
  • Example A10 2-(2,6-Diethyl-4-hydroxy-2,3,6-trimethyl-piperidine-1-yloxy)-.N.-(3- dimethylamino-propyl)-2-methyl-propionamide (Compound 110, Table 1) a) 2-Bromo-N-(3-dimethylamino-propyl)-2-methyl-propionamide
  • Example A11 Benzyl- ⁇ 3-[2-(2,6-diethyl-4-hydroxy-2,3,6-trimethyl-piperidine-1-yloxy)-2- methyl-propionylamino]-propyl ⁇ -dimethyl-ammonium-chloride (Compound 111 , Table
  • Example A12 Benzyl- ⁇ 3-[2-(2,6-diethyl-4-hydroxy-2,3,6-trimethyl-piperidine-1 -yloxy)- propionylamino]-propyl ⁇ -dimethyl-ammonium-chloride (Compound 112, Table 1)
  • Benzylchloride (3.8g, 0.03 mol) is added to a solution of 2-(2,6-diethyl-4-hydroxy-2,3,6- trimethyl-piperidine-1-yloxy)-.N.-(3-dimethylamino-propyl)-propionamide (10.1 g, 0.0272 mol) in acetonitrile (15 ml). The mixture is stirred for 18 h at room temperature and is then evaporated. The residue is triturated with diethylether to remove the excess of benzylchloride, the solid is filtered off and dried to afford 13.1 g of the title compound as a colorless amorphous solid.
  • 3-Bromopropanol (10.75 g, 0.075 mol) is added over 20 minutes to a solution of 2- bromopropionylbromide (17.9 g, 0.079 mol) in toluene (75 ml) while keeping the temperature between 15-20 °C.
  • the mixture is stirred for 6 h at room temperature and is then poured under vigorous stirring into 1 M solution of Na 2 C0 3 (80 ml).
  • the organic layer is separated, washed with water (3 x 50 ml), dried over MgS0 4 and evaporated to afford 19.75 g of the title compound as a colorless oil.
  • Tributylphosphine (3 ml, 0.012 mol) is added to a solution of 2-(2,6-diethyl-4-hydroxy-2,3,6- trimethyl-piperidine-1-yloxy)-propionic acid 3-bromo-propyl ester (4.08 g, 0.01 mol) in acetonitrile (5 ml). The solution is stirred under argon at 60° C for 23 h. The solvent is evaporated and the residue is triturated with diethyl ether (2 x 15 ml) to remove the excess of the phosphine. Drying of the oily, in ether insoluble, residue affords 6.45 g of the title compound as a thick resin.
  • 1 H-NMR 300 MHz, CDCI 3 ): 4.38-4.13 (m, 4H), 2.66-2.47 (m, 8H), 2.1 -0.83 (m, 49H).
  • NOR's n-butyl acrylate with cationic alkoxvamines
  • Example C1 Intercalation of Nanofil EXM 588 (Layered silicate of Montmorillonite-type from S ⁇ d Chemie, Germany) with compound 101.
  • Example D1 In a 50 ml round bottom flask with magnetic stirring and vacuum and nitrogen inlet 0.5 g with compound 101 intercalated Nanofil EXM588 in 9.5 g n-butyl acrylate (BASF, techn. quality) and 4.28 g 2-methoxypropyl acetat is dispersed and homogenized in an ultrasonic bath. After evacuation and purging 5 times with N 2 , the monomer is polymerized during 9 h at 140°C (bath temperature) under vigorous stirring. The monomer conversion, determined by 1 H-NMR, is 85%. The dispersion is subjected to centrifugation at 2000 rpm during 60 min and the sedimented solid washed with EtOAc and dried.
  • BASF techn. quality
  • 2-methoxypropyl acetat is dispersed and homogenized in an ultrasonic bath. After evacuation and purging 5 times with N 2 , the monomer is polymerized during 9 h at 140°C (bath temperature) under
  • the supernatant solution can be centrifuged during many hours (2000 rpm, corresponding to ca. 850 g), without further sedimentation. Even after 10-fold dilution with EtOAC it is stable for months (no sedimentation observed) which proves the nm size of the particles, indicating complete exfoliation.
  • the dispersion is diluted with 240 ml toluene and 20 min centrifuged at 2000 rpm. After washing and drying 0.35 g of a solid is obtained which corresponds according to TGA analysis to pure with ⁇ . ⁇ '-azodiisobutyramidine-dihydrochloride intercalated Nanofil EXM588 and contains no polymer!
  • the supernatant solution is completely evaporated and the residue dissolved in 150 ml THF. Centrifugation 1 h with 2000 rpm gives again 50 mg with ⁇ , ⁇ '-azodiisobutyramidine- dihydrochloride intercalated Nanofil EXM588.
  • inventive example D1 shows that the exfoliation of the layered silicate using intercalated NOR (ex. 1 ) followed by controlled radical polymerization is much more efficient: Firstly a much higher monomer conversion (85% compared to 20%) is obtained; secondly only a small amount of the layered silicate is not exfoliated (11.4% compared with 80% in ex. 1), which can be explained by an efficient initiation in all layers, and thirdly the formed polymer has a much lower, controlled molecular weight.
  • Example D2 In analogy to example D1 , the controlled radical polymerization of styrene is used to exfoliate the sheet silicate Nanofil EXM588, intercalated with the cationic NOR compound 104.
  • the exfoliated sheet silicate contains 66 wt.% polystyrene and 34 wt.% sheet silicate as measured by TGA.
  • Example D3 In analogy to example D1 , 10 g with compound 104 intercalated Nanofil EXM588 (ex. 7), 40 g n-butyl acrylate (BASF, techn. quality) and 120 g 2-methoxypropyl acetat is dispersed in a 350 ml round bottom flask with an ultraturax mixer during 25 min. After evacuation and purging 5 times with N 2 , the monomer is polymerized during 18 h at 140°C (oil bath temperature: 155°C) with mechanical stirring. The monomer conversion, determined by 1 H-NMR, is 33%. The dispersion is diluted with 100 ml EtOH and subjected to centrifugation at 2000 rpm during 60 min.
  • GPC gives a molar mass M n of 3380 and M F ⁇ l ⁇ O, corresponding to a PDI of 1.52 and therefore the polymerization is well controlled.
  • the supernatant solution is also evaporated and dried: 18.75 g solid.
  • Weight loss measured by TGA 25° to 600°C, 10°C/min) gives 60 wt.% polymer attached to the sheet silicate (40 wt.%).
  • Example D4 In analogy to example D3, 7.5 g with compound 111 intercalated Nanofil EXM588 (ex. 9), 40 g n-butyl acrylate (BASF, techn. quality) and 120 g 2-methoxypropyl acetat is dispersed in a 350 ml round bottom flask with an ultraturax mixer during 25 min. After evacuation and purging 5 times with N 2 , the monomer is polymerized during 19 h at 140°C (oil bath temperature: 155°C) with mechanical stirring. The dispersion is put into a rotavap and all the solvents are evaporated.
  • BASF n-butyl acrylate
  • 2-methoxypropyl acetat 2-methoxypropyl acetat
  • the highly viscous solid is than put into a Soxhlet extraction apparatus and continuously extracted with 300 ml EtOAc during 18 h. The remaining solid is dried in high vacuum at 90°C over night: 15.5 g of a grey solid is obtained.
  • Weight loss measured by TGA 25° to 600°C, 10°C/min gives 64 wt.% polymer attached to the sheet silicate (36 wt.%).
  • Example D5 In analogy to example D4, 7.5 g with compound 111 intercalated Nanofil EXM588 (ex. 9), 32.5 g styrene (Fluka, purum) and 75 g butylacetate (Fluka, purum) is dispersed in a 350 ml round bottom flask with an ultraturax mixer during 25 min. After evacuation and purging 5 times with N 2 , the monomer is polymerized during 24 h at 120°C with mechanical stirring. The dispersion is precipitated in EtOH and the solid dried in a vacuum oven at 50°C over night: 20 g of white solid.
  • Weight loss measured by TGA (25° to 600°C, 10°C/min) gives 72 wt.% polymer attached to the sheet silicate (28 wt.%).
  • Example D6 In analogy to example D4, 5 g with compound 111 intercalated Optigel SH, 25.8 g n-butyl acrylate (BASF, techn. quality) and 77.3 g 2-methoxypropyl acetate (Fluka, purum) is dispersed in a 350 ml round bottom flask with an ultraturax mixer during 25 min. After evacuation and purging 5 times with N 2 , the monomer is polymerized during 19 h at 140°C with mechanical stirring. The dispersion is put into a rotavap and all the solvents are evaporated. The paste is than put into a Soxhlet extraction apparatus and continuously extracted with 300 ml EtOAc during 18 h.
  • BASF techn. quality
  • 2-methoxypropyl acetate Fluka, purum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Manufacturing & Machinery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polymerisation Methods In General (AREA)
  • Paints Or Removers (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Sealing Material Composition (AREA)
PCT/EP2003/006370 2002-06-24 2003-06-17 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays Ceased WO2004000809A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2004514745A JP4640936B2 (ja) 2002-06-24 2003-06-17 カチオン性アルコキシアミン、及び天然又は合成粘土由来のナノ粒子の製造における使用
KR1020047021209A KR101015028B1 (ko) 2002-06-24 2003-06-17 양이온성 알콕시아민, 및 천연 또는 합성 점토로부터 나노입자 제조시 이의 용도
EP03740262A EP1515950B1 (en) 2002-06-24 2003-06-17 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
CA002486958A CA2486958A1 (en) 2002-06-24 2003-06-17 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
AT03740262T ATE450509T1 (de) 2002-06-24 2003-06-17 Kationische alkoxyaminen zur verwendung in der herstellung von nanopartikeln von natürlichen oder synthetischen clays
AU2003279373A AU2003279373A1 (en) 2002-06-24 2003-06-17 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
DE60330340T DE60330340D1 (de) 2002-06-24 2003-06-17 Kationische alkoxyaminen zur verwendung in der herstellung von nanopartikeln von natürlichen oder synthetischen clays
US10/519,030 US7595359B2 (en) 2002-06-24 2003-06-17 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
MXPA04012885A MXPA04012885A (es) 2002-06-24 2003-06-17 Alcoxiamidas cationicas y su uso para producir nanoparticulas de arcillas naturales o sinteticas.
US12/535,747 US7902368B2 (en) 2002-06-24 2009-08-05 Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02405520 2002-06-24
EP02405520.4 2002-06-24

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10519030 A-371-Of-International 2003-06-17
US12/535,747 Division US7902368B2 (en) 2002-06-24 2009-08-05 Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines

Publications (1)

Publication Number Publication Date
WO2004000809A1 true WO2004000809A1 (en) 2003-12-31

Family

ID=29797353

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/006370 Ceased WO2004000809A1 (en) 2002-06-24 2003-06-17 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays

Country Status (11)

Country Link
US (2) US7595359B2 (enExample)
EP (1) EP1515950B1 (enExample)
JP (1) JP4640936B2 (enExample)
KR (1) KR101015028B1 (enExample)
CN (1) CN1662499A (enExample)
AT (1) ATE450509T1 (enExample)
AU (1) AU2003279373A1 (enExample)
CA (1) CA2486958A1 (enExample)
DE (1) DE60330340D1 (enExample)
MX (1) MXPA04012885A (enExample)
WO (1) WO2004000809A1 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076419A1 (en) * 2003-02-26 2004-09-10 Ciba Specialty Chemicals Holding Inc. Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
DE10353890A1 (de) * 2003-11-17 2005-06-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Nanokomposite auf der Basis von Schichtsilikaten und deren Anwendung
WO2006064446A1 (en) 2004-12-15 2006-06-22 Koninklijke Philips Electronics N.V. Calibration of optical analysis making use of multivariate optical elements
WO2006101560A2 (en) 2005-03-16 2006-09-28 Arkema Inc. Clays pre-activated with intercalated polymerization sites
US7550599B2 (en) 2003-02-26 2009-06-23 Ciba Specialty Chemicals Corporation Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
US7659321B2 (en) 2004-11-17 2010-02-09 Cornell Research Foundation, Inc. Photoinitiator anchored to silicate and use thereof to prepare polymer exfoliated silicate nanocomposite

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2843394B1 (fr) * 2002-08-07 2005-12-30 Atofina Alcoxyamines issues de nitroxydes b-phosphore, leur utilisation en polymerisation radicalaire
WO2004063268A1 (en) 2003-01-15 2004-07-29 Ciba Specialty Chemicals Holding Inc. Stabilization of thermoplastic nanocomposites
SG175605A1 (en) * 2006-11-30 2011-11-28 Texas A & M Univ Sys Intercalation agent free compositions useful to make nanocomposite polymers
CN114849654B (zh) * 2022-05-13 2023-03-17 成都理工大学 一种草酸插层膨胀高岭土的制备方法及吸附应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024756A2 (en) * 2000-09-21 2002-03-28 Rohm And Haas Company Hydrophobically modified clay polymer nanocomposites

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204473A (en) * 1987-09-21 1993-04-20 Ciba-Geigy Corporation O-substituted N-hydroxy hindered amine stabilizers
US5096950A (en) * 1988-10-19 1992-03-17 Ciba-Geigy Corporation Polyolefin compositions stabilized with NOR-substituted hindered amines
US5004770A (en) * 1988-10-19 1991-04-02 Ciba-Geigy Corporation Polymeric substrates stabilized with N-substituted hindered amines
US4972009A (en) * 1989-08-18 1990-11-20 Ciba-Geigy Corporation Polymer stabilizers containing both hindered amine and nitrone moieties
US5627248A (en) * 1995-09-26 1997-05-06 The Dow Chemical Company Difunctional living free radical polymerization initiators
USH1957H1 (en) * 1997-10-29 2001-04-03 Basf Aktiengesellschaft Immediate termination of free radical polymerizations
TWI246519B (en) * 1998-06-25 2006-01-01 Ciba Sc Holding Ag Use of 2,2,6,6 tetraalkylpiperidine-N-oxyl radicals having long alkyl chains as polymerization regulators
US6392041B1 (en) * 1999-02-25 2002-05-21 Ciba Specialty Chemicals Corporation Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith
US6559207B1 (en) * 2000-03-14 2003-05-06 Si Corporation Flame resistant polymer composition and method for rendering polymers flame resistant
US6492521B2 (en) * 2000-11-03 2002-12-10 Cytec Technology Corp. Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same
US6727300B2 (en) * 2000-11-03 2004-04-27 Cytec Technology Corp. Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds
US6414155B1 (en) * 2000-11-03 2002-07-02 Cytec Technology Corp. Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same
TWI273115B (en) * 2000-12-12 2007-02-11 Ciba Sc Holding Ag Improved weatherability of flame retardant polyolefin
AU2002363869A1 (en) * 2001-12-21 2003-07-09 Ciba Specialty Chemicals Holding Inc. Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines
ATE439401T1 (de) * 2001-12-21 2009-08-15 Basf Se Neue flammhemmer
US7323502B2 (en) * 2002-03-12 2008-01-29 Ciba Specialty Chemicals Corporation Flame retardant compositions
US7109260B2 (en) * 2002-10-17 2006-09-19 Ciba Specialty Chemicals Corporation Flame retardant compositions
MY139230A (en) * 2002-10-17 2009-08-28 Ciba Holding Inc Flame retardant polymeric electrical parts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024756A2 (en) * 2000-09-21 2002-03-28 Rohm And Haas Company Hydrophobically modified clay polymer nanocomposites

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARC W. WEIMER ET AL.: "Direct Synthesis of Dispersed Nanocomposites by in Situ Living Free Radical Polymerization Using a Silicate-Anchored Initiator", J. AM. CHEM. SOC., vol. 121, 1999, pages 1615 - 16, XP002259135 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004076419A1 (en) * 2003-02-26 2004-09-10 Ciba Specialty Chemicals Holding Inc. Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
US7550599B2 (en) 2003-02-26 2009-06-23 Ciba Specialty Chemicals Corporation Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
US7947832B2 (en) 2003-02-26 2011-05-24 Basf Se Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
US8013162B2 (en) 2003-02-26 2011-09-06 Ciba Corporation Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
DE10353890A1 (de) * 2003-11-17 2005-06-23 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Nanokomposite auf der Basis von Schichtsilikaten und deren Anwendung
US7659321B2 (en) 2004-11-17 2010-02-09 Cornell Research Foundation, Inc. Photoinitiator anchored to silicate and use thereof to prepare polymer exfoliated silicate nanocomposite
WO2006064446A1 (en) 2004-12-15 2006-06-22 Koninklijke Philips Electronics N.V. Calibration of optical analysis making use of multivariate optical elements
WO2006101560A2 (en) 2005-03-16 2006-09-28 Arkema Inc. Clays pre-activated with intercalated polymerization sites
WO2006101560A3 (en) * 2005-03-16 2007-10-18 Arkema Inc Clays pre-activated with intercalated polymerization sites
EP1858967A4 (en) * 2005-03-16 2014-07-30 Pmc Organometallix Inc PRE-ACTIVATED TONE WITH INTERCALED POLYMERIZATION SITES

Also Published As

Publication number Publication date
CN1662499A (zh) 2005-08-31
KR20050014021A (ko) 2005-02-05
KR101015028B1 (ko) 2011-02-16
US7595359B2 (en) 2009-09-29
EP1515950A1 (en) 2005-03-23
EP1515950B1 (en) 2009-12-02
ATE450509T1 (de) 2009-12-15
JP2005538964A (ja) 2005-12-22
DE60330340D1 (de) 2010-01-14
MXPA04012885A (es) 2005-03-31
CA2486958A1 (en) 2003-12-31
US20090306382A1 (en) 2009-12-10
US7902368B2 (en) 2011-03-08
JP4640936B2 (ja) 2011-03-02
US20050215691A1 (en) 2005-09-29
AU2003279373A1 (en) 2004-01-06

Similar Documents

Publication Publication Date Title
US7902368B2 (en) Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines
US4161592A (en) Piperidinyl-s-triazines
RU2719592C2 (ru) Способ получения ацилфосфатов
Böttcher et al. Organic/inorganic hybrids by ‘living’/controlled ATRP grafting from layered silicates
KR101991272B1 (ko) 트리알콕시실릴알킬기를 갖는 오늄염
KR20170140138A (ko) 전기화학 장치를 위한 새로운 부류의 단일 이온 전도 중합체 제조용 신규 가교 링커 및 상기 중합체
EP2013240B1 (en) Process for the preparation of crosslinked nitroxide polymers
EP1189875B1 (en) Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
US7199245B2 (en) 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
US4297492A (en) Phenolic-1,3,5-triazines
EP0035291B1 (en) Process for carrying out radical reactions and shaped articles of the reaction product
US7781509B2 (en) Clays pre-activated with intercalated polymerization initiation sites
CN102216338B (zh) 高分子系纳米复合材料的制造方法以及通过该制造方法形成的阻燃性高分子系纳米复合材料
JP2005097028A (ja) 有機変性層状珪酸塩およびその組成物
GB1569669A (en) Phosphorus-containing piperidine compounds
Chirowodza Polymer-clay nanocomposites prepared by RAFT-supported grafting
WO2008017757A2 (fr) Materiau a structure lamellaire modifie, de type polysilicate ou phosphate de zirconium et/ou de titane, modifie par un oligoamide, son procede de preparation et son utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003740262

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2486958

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2004/012885

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 10519030

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 20038146657

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 1020047021209

Country of ref document: KR

Ref document number: 2004514745

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 1020047021209

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003740262

Country of ref document: EP